The DOI matches its Crossref record.
A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits
Abstract
Despite antibiotic therapy, the septic shock syndrome continues to have a high mortality. Tumor necrosis factor (TNF) and interleukin 1 (IL 1), two polypeptide cytokines produced during sepsis, are thought to mediate the hypotension and tissue damage of shock. In the present studies, rabbits were infused with Escherichia coli organisms to produce shock. The IL 1 receptor antagonist (IL 1ra), which competes with IL 1 for occupancy of the IL 1 cell‐surface receptors without agonist properties, was given 15 min before the bacterial infusion and during the subsequent 4 h. In saline‐treated controls, hypotension was sustained for 4 h and death occurred for two of five rabbits; in rabbits treated with the IL 1ra, however, blood pressure was only transiently decreased, returned to pre‐ E. coli levels, and no deaths occurred. The associated leukopenia was also reduced by treatment with the antagonist ( P < 0.05). Histological examination of lung tissues showed reduced infiltrating neutrophils in the IL 1ra treatment group. Despite the attenuated responses in animals treated with the IL 1ra, circulating TNF and IL 1 levels were nearly identical in both groups. We conclude that specific blockade of IL 1 at the receptor level demonstrates an essential role for this cytokine in the pathogenesis of septic shock.—Wakabayashi, G.; Gelfand, J. A.; Burke, J. F.; Thompson, R. C.; Dinarello, C. A. A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits. FASEB J. 5: 338–343; 1991.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationOpal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.547 · Cited by 796
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Self-citationThe balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Glauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors
Brigelius-Flohé, R., & Flohé, L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3534 · Cited by 576
Berg, D. J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G., & Rennick, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118290 · Cited by 535
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome
Dinarello, C. A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140081040 · Cited by 405
Self-citationDinarello, C. A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1177 · Cited by 397
Self-citationGodin, P. J., & Buchman, T. G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00008 · Cited by 377
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., & Bloedow, D. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115748 · Cited by 333
Vannier, E., Miller, L. C., & Dinarello, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4076 · Cited by 321
Self-citationGram-positive Organisms and Sepsis
Bone, R. C. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.26 · Cited by 315
Production of interleukin-1-receptor antagonist during experimental endotoxaemia
Granowitz, E. V., Poutsiaka, D. D., Cannon, J. G., Wolff, S. M., Dinarello, C. A., Santos, A. A., & Wilmore, D. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)92725-h · Cited by 310
Self-citationThiemermann, C. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00410-7 · Cited by 303
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Cytokines and Metabolic Dysfunction After Severe Head Injury
OTT, L., McCLAIN, C. J., GILLESPIE, M., & YOUNG, B. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.447 · Cited by 266
Role of the neutrophil in adult respiratory distress syndrome
Windsor, A. C. J., Mullen, P. G., Fowler, A. A., & Sugerman, H. J. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800106 · Cited by 259
Tilg, H., Vannier, E., Vachino, G., Dinarello, C. A., & Mier, J. W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1629 · Cited by 256
Self-citationWhy immunomodulatory therapies have not worked in sepsis
Abraham, E. (1999) · Intensive Care Medicine · doi:10.1007/s001340050903 · Cited by 252
Gram-Negative Sepsis and the Adult Respiratory Distress Syndrome
Martin, M. A., & Silverman, H. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1213 · Cited by 109
KAPCALA, L. P., CHAUTARD, T., & ESKAY, R. L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44699.x · Cited by 103
Sleep, sleep deprivation and infectious disease: Studies in animals
Toth, L. A. (1995) · Advances in Neuroimmunology · doi:10.1016/0960-5428(94)00045-p · Cited by 93
Cartmell, T., Luheshi, G. N., Hopkins, S. J., Rothwell, N. J., & Poole, S. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0171j.x · Cited by 62
Horino, T., Matsumoto, T., Uramatsu, M., Tanabe, M., Tateda, K., Miyazaki, S., Nakane, A., Iwakura, Y., & Yamaguchi, K. (2005) · Cytokine · doi:10.1016/j.cyto.2005.01.002 · Cited by 13
Metadata
- Authors
- Wakabayashi, G., Gelfand, J. A., Burke, J. F., Thompson, R. C., & Dinarello, C. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1991-03
- Volume
- 5
- Issue
- 3
- Pages
- 338-343
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1497298414
- Cited by
- 423
- References
- 0
- FWCI
- 62.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.